IRIS
ELENA, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.293
EU - Europa 1.071
AS - Asia 702
SA - Sud America 59
OC - Oceania 8
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.140
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.273
CN - Cina 549
IE - Irlanda 376
RU - Federazione Russa 149
FI - Finlandia 127
SG - Singapore 104
DE - Germania 97
IT - Italia 95
UA - Ucraina 91
BR - Brasile 52
SE - Svezia 37
GB - Regno Unito 28
FR - Francia 21
HK - Hong Kong 19
BE - Belgio 18
CA - Canada 17
NL - Olanda 10
AT - Austria 7
AU - Australia 6
AZ - Azerbaigian 5
IN - India 5
AR - Argentina 4
JP - Giappone 4
EU - Europa 3
LT - Lituania 3
EC - Ecuador 2
GR - Grecia 2
IQ - Iraq 2
NZ - Nuova Zelanda 2
PL - Polonia 2
RO - Romania 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
MU - Mauritius 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
PY - Paraguay 1
UZ - Uzbekistan 1
Totale 3.140
Salva come PNG Salva come JPEG
Città #
Dublin 376
Chandler 232
Nanjing 163
Jacksonville 144
Boardman 110
Ashburn 104
Nanchang 67
Ann Arbor 63
Singapore 61
Princeton 58
Lawrence 56
Beijing 54
Medford 54
Wilmington 50
Helsinki 47
Changsha 46
Hebei 38
Jiaxing 37
Shenyang 35
Pavia 31
New York 30
Moscow 24
Shanghai 24
Hangzhou 20
Brussels 18
Hong Kong 18
Milan 16
Toronto 15
Tianjin 14
Los Angeles 12
Norwalk 12
Woodbridge 12
Jinan 7
Nuremberg 7
Seattle 7
Belo Horizonte 6
Fairfield 5
Falkenstein 5
Falls Church 5
Houston 5
Kunming 5
Verona 5
Vienna 5
Washington 5
Baku 4
Frankfurt am Main 4
Ningbo 4
Pune 4
São Paulo 4
Florence 3
Guangzhou 3
Redwood City 3
Reston 3
San Francisco 3
Taizhou 3
Tappahannock 3
Tokyo 3
Zhengzhou 3
Athens 2
Auckland 2
Blumenau 2
Brasília 2
Canberra 2
Düsseldorf 2
Fuzhou 2
London 2
Monza 2
Naples 2
Paris 2
Petrolândia 2
Porto Alegre 2
Santa Clara 2
Sesto San Giovanni 2
Almaty 1
Alta Floresta 1
Amarante 1
Amman 1
Andover 1
Andradina 1
Araçatuba 1
Auburn Hills 1
Baghdad 1
Baqa al-Gharbiyye 1
Bishkek 1
Bolgare 1
Buenos Aires 1
Cairo 1
Canela 1
Canoinhas 1
Caratinga 1
Casablanca 1
Central 1
Centro do Guilherme 1
Cerquilho 1
Changchun 1
Chongqing 1
Ciudad del Este 1
Colombo 1
Como 1
Coronel Fabriciano 1
Totale 2.212
Salva come PNG Salva come JPEG
Nome #
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis 109
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. 98
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. 89
Blast phase of essential thrombocythemia: A single center study. 87
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations 86
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 76
Clinical significance of somatic mutation in unexplained blood cytopenia 75
Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2. 73
Clinical relevance of murine double minute 2 single nucleotide polymorphisms 309 in familial myeloproliferative neoplasm. 72
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients 71
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 70
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms 69
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. 68
Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia 68
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia 67
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea 66
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera. 65
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 63
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders 63
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts 63
Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence. 62
Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms. 62
Clinical significance of genetic aberrations in secondary acute myeloid leukemia. 62
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome 61
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. 60
Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation 59
Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm 57
Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms 56
Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation. 54
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. 54
Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis 53
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions 53
Mutational status of myeloproliferative neoplasms. 52
Incidence and Prognosis of Clonal Hematopoiesis in patients with Chronic Idiopathic Neutropenia 51
‘Real-life’ study of imatinib therapy in chronic phase-chronic myeloid leukemia: A novel retrospective observational longitudinal analysis 50
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation 50
Risk of hepatitis B reactivation under treatment with tyrosine-kinase inhibitors for chronic myeloid leukemia 49
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients 47
Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS. 46
The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications 46
Somatic mutations of calreticulin in myeloproliferative neoplasms 46
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis 46
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis 45
JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms. 44
HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemia 44
Pregnancy complications predict thrombotic events in young women with essential thrombocythemia 43
Relationship between clone metrics and clinical outcome in clonal cytopenia 42
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes 37
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification 37
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes 36
Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: A real clinical problem? 33
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications 32
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry 32
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. 30
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. 30
Validation of cytogenetic-based risk stratification in primary myelofibrosis. 29
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives. 26
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes. 25
Telangiectasia macularis eruptiva perstans: a neglected type of mastocytosis with exclusively cutaneous involvement? A case series 21
A cross‐sectional study on quality of life in adult indolent systemic mastocytosis and its association with cutaneous involvement 15
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry 14
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis 11
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis 9
Unusual widespread cutaneous eruption due to nilotinib therapy for chronic myeloid leukemia 6
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry 4
Totale 3.319
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.411
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202074 0 0 0 0 0 0 0 0 0 43 30 1
2020/2021223 26 19 4 21 2 18 12 40 17 32 21 11
2021/2022289 5 3 3 6 5 7 4 16 13 21 40 166
2022/2023836 77 60 5 43 80 61 0 38 423 6 30 13
2023/2024368 53 59 21 23 27 100 1 29 3 5 8 39
2024/2025591 22 71 26 21 28 63 62 67 211 20 0 0
Totale 3.319